Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy selections remain limited. Use the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Take a look https://financefeeds.com/scila-ab-appoints-fredrik-backlund-as-head-of-marketing-communications/